Mr. Speaker, the hon. member's question is about a week late.
I announced last week that we are going to have the most open and transparent method of approving drugs, and then the most open and transparent method of surveillance of drugs after they have been approved for market. It is important that we do that. It is important for the health of each and every Canadian who takes those drugs.